138 related articles for article (PubMed ID: 37191806)
1. Illuminating DEPDC1B in Multi-pronged Regulation of Tumor Progression.
Boudreau HE; Robinson J; Kasid UN
Methods Mol Biol; 2023; 2660():295-310. PubMed ID: 37191806
[TBL] [Abstract][Full Text] [Related]
2. DEPDC1B Promotes Melanoma Angiogenesis and Metastasis through Sequestration of Ubiquitin Ligase CDC16 to Stabilize Secreted SCUBE3.
Hu F; Fong KO; Cheung MPL; Liu JA; Liang R; Li TW; Sharma R; Ip PP; Yang X; Cheung M
Adv Sci (Weinh); 2022 Apr; 9(10):e2105226. PubMed ID: 35088579
[TBL] [Abstract][Full Text] [Related]
3. DEPDC1B coordinates de-adhesion events and cell-cycle progression at mitosis.
Marchesi S; Montani F; Deflorian G; D'Antuono R; Cuomo A; Bologna S; Mazzoccoli C; Bonaldi T; Di Fiore PP; Nicassio F
Dev Cell; 2014 Nov; 31(4):420-33. PubMed ID: 25458010
[TBL] [Abstract][Full Text] [Related]
4. A putative novel protein, DEPDC1B, is overexpressed in oral cancer patients, and enhanced anchorage-independent growth in oral cancer cells that is mediated by Rac1 and ERK.
Su YF; Liang CY; Huang CY; Peng CY; Chen CC; Lin MC; Lin RK; Lin WW; Chou MY; Liao PH; Yang JJ
J Biomed Sci; 2014 Aug; 21(1):67. PubMed ID: 25091805
[TBL] [Abstract][Full Text] [Related]
5. A MEK-independent role for CRAF in mitosis and tumor progression.
Mielgo A; Seguin L; Huang M; Camargo MF; Anand S; Franovic A; Weis SM; Advani SJ; Murphy EA; Cheresh DA
Nat Med; 2011 Nov; 17(12):1641-5. PubMed ID: 22081024
[TBL] [Abstract][Full Text] [Related]
6. DEPDC1B is a key regulator of myoblast proliferation in mouse and man.
Figeac N; Pruller J; Hofer I; Fortier M; Ortuste Quiroga HP; Banerji CRS; Zammit PS
Cell Prolif; 2020 Jan; 53(1):e12717. PubMed ID: 31825138
[TBL] [Abstract][Full Text] [Related]
7. ZNF146 regulates cell cycle progression via TFDP1 and DEPDC1B in ovarian cancer cells.
Zhao R; Song N; Ning X; Chen X; Ma R
Reproduction; 2024 Jul; 168(1):. PubMed ID: 38614125
[TBL] [Abstract][Full Text] [Related]
8. Expression of BRCC3, a novel cell cycle regulated molecule, is associated with increased phospho-ERK and cell proliferation.
Boudreau HE; Broustas CG; Gokhale PC; Kumar D; Mewani RR; Rone JD; Haddad BR; Kasid U
Int J Mol Med; 2007 Jan; 19(1):29-39. PubMed ID: 17143545
[TBL] [Abstract][Full Text] [Related]
9. DEPDC1B knockdown inhibits the development of malignant melanoma through suppressing cell proliferation and inducing cell apoptosis.
Xu Y; Sun W; Zheng B; Liu X; Luo Z; Kong Y; Xu M; Chen Y
Exp Cell Res; 2019 Jun; 379(1):48-54. PubMed ID: 30880030
[TBL] [Abstract][Full Text] [Related]
10. DEPDC1B promotes development of cholangiocarcinoma through enhancing the stability of CDK1 and regulating malignant phenotypes.
Zhang Z; Wang X; Nie P; Qin Y; Shi J; Xu S
Front Oncol; 2022; 12():842205. PubMed ID: 36568241
[TBL] [Abstract][Full Text] [Related]
11. CDC25B phosphorylation by Aurora-A occurs at the G2/M transition and is inhibited by DNA damage.
Cazales M; Schmitt E; Montembault E; Dozier C; Prigent C; Ducommun B
Cell Cycle; 2005 Sep; 4(9):1233-8. PubMed ID: 16082213
[TBL] [Abstract][Full Text] [Related]
12. Arrested detachment: a DEPDC1B-mediated de-adhesion mitotic checkpoint.
Garcia-Mata R
Dev Cell; 2014 Nov; 31(4):387-9. PubMed ID: 25458006
[TBL] [Abstract][Full Text] [Related]
13. Establishment of rat anti-canine DEP domain containing 1B (DEPDC1B) monoclonal antibodies.
Igase M; Morinaga Y; Kato M; Tsukui T; Sakai Y; Okuda M; Mizuno T
J Vet Med Sci; 2020 Apr; 82(4):483-487. PubMed ID: 32147621
[TBL] [Abstract][Full Text] [Related]
14. DEPDC1B collaborates with GABRD to regulate ESCC progression.
Yuan Y; Ping W; Zhang R; Hao Z; Zhang N
Cancer Cell Int; 2022 Jun; 22(1):214. PubMed ID: 35706026
[TBL] [Abstract][Full Text] [Related]
15. Cdk1 activity is required for mitotic activation of aurora A during G2/M transition of human cells.
Van Horn RD; Chu S; Fan L; Yin T; Du J; Beckmann R; Mader M; Zhu G; Toth J; Blanchard K; Ye XS
J Biol Chem; 2010 Jul; 285(28):21849-57. PubMed ID: 20444701
[TBL] [Abstract][Full Text] [Related]
16. DEPDC1B enhances malignant phenotypes of multiple myeloma through upregulating CCNB1 and inhibiting p53 signaling pathway.
Fei H; Shi X; Li S; Li Y; Yin X; Wu Z; Wang W; Shi H; Li R
Tissue Cell; 2024 Feb; 86():102263. PubMed ID: 37979396
[TBL] [Abstract][Full Text] [Related]
17. DEPDC1B promotes migration and invasion in pancreatic ductal adenocarcinoma by activating the Akt/GSK3β/Snail pathway.
Liu X; Li T; Huang X; Wu W; Li J; Wei L; Qian Y; Xu H; Wang Q; Wang L
Oncol Lett; 2020 Nov; 20(5):146. PubMed ID: 32934714
[TBL] [Abstract][Full Text] [Related]
18. DEP Domain-Containing Protein 1B (DEPDC1B) Promotes Migration and Invasion in Pancreatic Cancer Through the Rac1/PAK1-LIMK1-Cofilin1 Signaling Pathway.
Zhang S; Shi W; Hu W; Ma D; Yan D; Yu K; Zhang G; Cao Y; Wu J; Jiang C; Wang Z
Onco Targets Ther; 2020; 13():1481-1496. PubMed ID: 32110046
[TBL] [Abstract][Full Text] [Related]
19. Integrative RNA profiling of TBEV-infected neurons and astrocytes reveals potential pathogenic effectors.
Selinger M; Věchtová P; Tykalová H; Ošlejšková P; Rumlová M; Štěrba J; Grubhoffer L
Comput Struct Biotechnol J; 2022; 20():2759-2777. PubMed ID: 35685361
[TBL] [Abstract][Full Text] [Related]
20. High Expression of DEPDC1B Predicts Poor Prognosis in Lung Adenocarcinoma.
Li P; Chen X; Zhou S; Xia X; Wang E; Han R; Zeng D; Fei G; Wang R
J Inflamm Res; 2022; 15():4171-4184. PubMed ID: 35912402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
